Prime Medicine, Inc. (PRME)

NASDAQ: PRME · Real-Time Price · USD

1.460

0.00 (0.00%)

At close: Jun 13, 2025, 4:00 PM

1.520

+0.060 (4.11%)

After-hours: Jun 13, 2025, 7:56 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '20 Dec 31, 2020
Genetic Therapies	2.98M	Log In
Genetic Therapies Growth	-42.74%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '20 Dec 31, 2020
United States	2.98M	Log In
United States Growth	-42.74%	Log In